학술논문

Pancreatic islet-specific engineered Tregs exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models.
Document Type
Article
Source
Science Translational Medicine; 10/5/2022, Vol. 14 Issue 665, p1-18, 18p
Subject
TYPE 1 diabetes
IMMUNOSUPPRESSION
REGULATORY T cells
T cell receptors
ISLANDS
T cells
ISLANDS of Langerhans
Language
ISSN
19466234
Abstract
Copyright of Science Translational Medicine is the property of American Association for the Advancement of Science and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)